(Q34489390)

2 August 2017

1 reference

title

Costs of irritable bowel syndrome in the UK and US. (English)

1 reference

2 August 2017

main subject

irritable bowel syndrome

1 reference

inferred from title

author name string

Stefanie Maxion-Bergemann

1

1 reference

2 August 2017

Frank Thielecke

2

1 reference

2 August 2017

Florian Abel

3

1 reference

2 August 2017

Rito Bergemann

4

1 reference

2 August 2017

publication date

1 January 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

24

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

21-37

1 reference

2 August 2017

1 reference

12 December 2020

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

1 reference

12 December 2020

Costs of care for irritable bowel syndrome patients in a health maintenance organization

1 reference

12 December 2020

Serotonergic modulation and irritable bowel syndrome

1 reference

12 December 2020

Diagnosis of irritable bowel syndrome

1 reference

12 December 2020

1 reference

12 December 2020

The burden of selected digestive diseases in the United States.

1 reference

12 December 2020

Diagnosis and care of irritable bowel syndrome in a community-based population.

1 reference

12 December 2020

Irritable bowel syndrome: prevalence, prognosis and consequences.

1 reference

12 December 2020

Functional digestive disorders (FDD) in the year 2000--economic impact.

1 reference

12 December 2020

Irritable bowel syndrome: definition, diagnosis and epidemiology

1 reference

12 December 2020

Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters

1 reference

12 December 2020

Cost-effectiveness of endoscopy in irritable bowel syndrome

1 reference

12 December 2020

Prevalence of gastrointestinal symptoms in the elderly: a population-based study

1 reference

12 December 2020

Resource utilization associated with irritable bowel syndrome in the United States 1987-1997.

1 reference

12 December 2020

Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.

1 reference

12 December 2020

Systematic review: the economic impact of irritable bowel syndrome.

1 reference

12 December 2020

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome

1 reference

12 December 2020

Clinical economics review: irritable bowel syndrome.

1 reference

12 December 2020

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

1 reference

12 December 2020

A population study on irritable bowel syndrome and mental health

1 reference

12 December 2020

Symptomatology, quality of life and economic features of irritable bowel syndrome--the effect of hypnotherapy

1 reference

12 December 2020

The economic impact of irritable bowel syndrome in a managed care setting

1 reference

12 December 2020

The economic consequences of irritable bowel syndrome: a US employer perspective

1 reference

12 December 2020

Irritable bowel syndrome: a technical review for practice guideline development

1 reference

12 December 2020

The economic burden of irritable bowel syndrome in Canada

1 reference

12 December 2020

Intergenerational transmission of gastrointestinal illness behavior

1 reference

12 December 2020

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

1 reference

12 December 2020

Irritable bowel syndrome: how far do you go in the workup?

1 reference

12 December 2020

Irritable bowel syndrome: update on pathogenesis and management

1 reference

12 December 2020

Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization

1 reference

12 December 2020

Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures

1 reference

12 December 2020

Irritable bowel syndrome in office-based practice in the United States

1 reference

12 December 2020

1 reference

12 December 2020

Irritable bowel syndrome symptom patterns: frequency, duration, and severity

1 reference

12 December 2020

Irritable bowel syndrome. A cost-effective approach for primary care physicians

1 reference

12 December 2020

Medical costs in community subjects with irritable bowel syndrome

1 reference

12 December 2020

Towards positive diagnosis of the irritable bowel

1 reference

12 December 2020

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective

1 reference

12 December 2020

Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?

1 reference

12 December 2020

Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications

1 reference

12 December 2020

10.2165/00019053-200624010-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1053725838

0 references

1 reference